FCGRT and neoplasm: Furthermore, as FcRn salvages IgG, and if decreased Fcgrt and FcRn expression are contributing to increased pembrolizumab CL in these models, we may also expect to see decreased IgG in tumour‐bearing vs. tumour‐free mice.